Crohn's Disease and Colitis Trial, Recruiting NCT06064864 Sponsor: Asan Medical Center Condition: Crohn's Disease and Colitis
Back to Crohns Disease And Colitis

Crohn's Disease and Colitis Trial, Recruiting

NCT06064864
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are 18 years old or older
  • You have been diagnosed with moderate to severe Crohn's disease, based on a standard disease activity score
  • Your Crohn's disease affects specific parts of your bowel (the ileum and/or colon), and this has been confirmed by a camera examination (colonoscopy) showing ulcers meeting certain levels of severity
  • A stool test or blood test shows signs of significant inflammation in your body
  • You have never previously been treated with any biologic medication (a type of advanced treatment made from living cells)
  • You have either not responded to, cannot tolerate, or are medically unable to take standard treatments such as steroids, immune-suppressing drugs, or antibiotics
  • You have freely agreed to take part and signed a consent form

Who may not be able to join:

  • You have had a previous allergic reaction to humanised protein-based medicines (confirm with trial site)
  • You have used steroid medications within the 8 weeks before your screening appointment
  • You currently have a narrowing of the intestine or back passage causing symptoms, an untreated abscess inside the abdomen or around the back passage, have had abdominal surgery within the last 6 months, or are expected to need bowel surgery during the study — though people who have had an abscess properly drained at least 4–8 weeks before the study starts may still be eligible (confirm with trial site)
  • You currently have active tuberculosis (TB) — though people who have been fully treated and confirmed cured may still be eligible (confirm with trial site)
  • You have latent (inactive) TB — though people who have completed or are near completing the proper treatment for latent TB may still be eligible (confirm with trial site)
  • You have tested positive for the hepatitis B surface antigen, or have certain other hepatitis B blood test results showing a high level of the virus in your blood (confirm with trial site)
  • You have tested positive for hepatitis C antibodies
  • You have a history of HIV infection or have tested positive for HIV
  • You have a serious heart condition classified as Class III or IV (meaning significant limitations on physical activity or symptoms at rest)
  • You currently have an active infection of any kind
  • You have or have had cancer in the last 5 years (certain skin cancers and cervical cancer may be exceptions — confirm with trial site), or have had pre-cancerous changes in the bowel within the last 5 years
  • You are currently pregnant or breastfeeding
  • You are not using, or do not plan to use, a reliable form of contraception for at least 6 months after your last dose of the study drug (accepted methods include hormonal contraceptives, condoms, diaphragm, coil, or abstinence)
  • The trial doctors have decided for any other reason that joining the trial would not be appropriate for you

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 20 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Byong Duk Ye, MD, PhD, Asan Medical Center

Phone: 82-2-3010-3181

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
9 October 2023
Est. completion
31 December 2026

Where this trial is recruiting

🇰🇷 South Korea

Primary endpoints

Deep remission rate of Arm 3 compared with Arm 2

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov